Janku F - Search Results

1

Non-small-cell lung cancer with HER2 exon 20 mutation: regression with dual HER2 inhibition and anti-VEGF combination treatment.

Falchook GS, Janku F, Tsao AS, Bastida CC, Stewart DJ, Kurzrock R. Falchook GS, et al. Among authors: janku f. J Thorac Oncol. 2013 Feb;8(2):e19-20. doi: 10.1097/JTO.0b013e31827ce38e. J Thorac Oncol. 2013. PMID: 23328556 Free PMC article. No abstract available.

2

Adjuvant interferon in high-risk melanoma: end of the era?

Janku F, Kurzrock R. Janku F, et al. J Clin Oncol. 2010 Jan 10;28(2):e15-6; author reply e17-8. doi: 10.1200/JCO.2009.24.9326. Epub 2009 Nov 30. J Clin Oncol. 2010. PMID: 19949007 No abstract available.

3

Successful treatment of Castleman's disease with interleukin-1 receptor antagonist (Anakinra).

El-Osta H, Janku F, Kurzrock R. El-Osta H, et al. Among authors: janku f. Mol Cancer Ther. 2010 Jun;9(6):1485-8. doi: 10.1158/1535-7163.MCT-10-0156. Epub 2010 May 25. Mol Cancer Ther. 2010. PMID: 20501803 Free PMC article.

4

Patients with advanced head and neck cancers have similar progression-free survival on phase I trials and their last food and drug administration-approved treatment.

Garrido-Laguna I, Janku F, Falchook GS, Fu S, Hong DS, Naing A, Aaron J, Wang X, Kies M, Kurzrock R. Garrido-Laguna I, et al. Among authors: janku f. Clin Cancer Res. 2010 Aug 1;16(15):4031-7. doi: 10.1158/1078-0432.CCR-10-0672. Epub 2010 Jun 4. Clin Cancer Res. 2010. PMID: 20525754

5

Targeted therapy in non-small-cell lung cancer--is it becoming a reality?

Janku F, Stewart DJ, Kurzrock R. Janku F, et al. Nat Rev Clin Oncol. 2010 Jul;7(7):401-14. doi: 10.1038/nrclinonc.2010.64. Epub 2010 Jun 15. Nat Rev Clin Oncol. 2010. PMID: 20551945 Review.

6

Response of histiocytoses to imatinib mesylate: fire to ashes.

Janku F, Amin HM, Yang D, Garrido-Laguna I, Trent JC, Kurzrock R. Janku F, et al. J Clin Oncol. 2010 Nov 1;28(31):e633-6. doi: 10.1200/JCO.2010.29.9073. Epub 2010 Aug 23. J Clin Oncol. 2010. PMID: 20733125 No abstract available.

7

PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors.

Janku F, Tsimberidou AM, Garrido-Laguna I, Wang X, Luthra R, Hong DS, Naing A, Falchook GS, Moroney JW, Piha-Paul SA, Wheler JJ, Moulder SL, Fu S, Kurzrock R. Janku F, et al. Mol Cancer Ther. 2011 Mar;10(3):558-65. doi: 10.1158/1535-7163.MCT-10-0994. Epub 2011 Jan 7. Mol Cancer Ther. 2011. PMID: 21216929 Free PMC article.

8

Outcomes of patients with advanced non-small cell lung cancer treated in a phase I clinic.

Janku F, Tsimberidou AM, Wang X, Hong DS, Naing A, Gong J, Garrido-Laguna I, Parsons HA, Zinner RG, Kurzrock R. Janku F, et al. Oncologist. 2011;16(3):327-35. doi: 10.1634/theoncologist.2010-0308. Epub 2011 Feb 21. Oncologist. 2011. PMID: 21339262 Free PMC article.

9

Autophagy as a target for anticancer therapy.

Janku F, McConkey DJ, Hong DS, Kurzrock R. Janku F, et al. Nat Rev Clin Oncol. 2011 May 17;8(9):528-39. doi: 10.1038/nrclinonc.2011.71. Nat Rev Clin Oncol. 2011. PMID: 21587219 Review.

10

Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center.

Garrido-Laguna I, Janku F, Vaklavas C, Falchook GS, Fu S, Hong DS, Naing A, Tsimberidou AM, Wen S, Kurzrock R. Garrido-Laguna I, et al. Among authors: janku f. Cancer. 2012 Mar 1;118(5):1422-8. doi: 10.1002/cncr.26413. Epub 2011 Aug 5. Cancer. 2012. PMID: 21823111 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters